Evaluation of cardiac masses by real-time perfusion imaging echocardiography

Carregando...
Imagem de Miniatura
Citações na Scopus
22
Tipo de produção
article
Data de publicação
2015
Título da Revista
ISSN da Revista
Título do Volume
Editora
BIOMED CENTRAL LTD
Citação
CARDIOVASCULAR ULTRASOUND, v.13, article ID 23, 11p, 2015
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Diagnosis of cardiac masses is still challenging by echocardiography and distinguishing tumors from thrombi has important therapeutical implications. We sought to determine the diagnostic value of real-time perfusion echocardiography (RTPE) for cardiac masses characterization. Methods: We prospectively studied 86 patients, 23 with malignant tumors (MT), 26 with benign tumors (BT), 33 with thrombi and 6 with pseudotumors who underwent RTPE. Mass perfusion was analyzed qualitatively and blood flow volume (A), blood flow velocity (beta), and microvascular blood flow (A x beta) were determined by quantitative RTPE. Results: Logistic regression models showed that the probability of having a tumor increased by 15.8 times with a peripheral qualitative perfusion pattern, and 34.5 times with a central perfusion pattern, in comparison with the absence of perfusion. Using quantitative RTPE analysis, thrombi group had parameters of blood flow lower than tumor group. A values for thrombi, MT, and BT were 0.1 dB (0.01-0.22), 2.78 dB (1-7) and 2.58 dB (1.44-5), respectively; p < 0.05, while A x beta values were 0.0 dB/s(-1) (0.01-0.14), 2.00 dB/s(-1) (1-6), and 1.18 dB/s(-1) (0.52-3), respectively; p < 0.05. At peak dipyridamole stress, MT had greater microvascular blood volume than BT [A = 4.18 dB (2.14-7.93) versus A = 2.04 dB (1.09-3.55); p < 0.05], but no difference in blood flow [Ax beta = 2.46 dB/s(-1) (1.42-4.59) versus Ax beta = 1.55 dB/s [1] (0.51-4.08); p=NS]. An A value >3.28 dB at peak dipyridamole stress predicted MT (AUC = 0.75) and conferred 5.8-times higher chance of being MT rather than BT. Conclusion: RTPE demonstrated that cardiac tumors have greater microvascular blood volume and regional blood flow when compared with thrombi. Dipyridamole stress was useful in differentiating MT from BT.
Palavras-chave
Cardiac tumor, Contrast echocardiography, Dipyridamole stress echocardiography
Referências
  1. Abdelmoneim SS, 2008, ECHOCARDIOGR-J CARD, V25, P517, DOI 10.1111/j.1540-8175.2008.00654.x
  2. Abdelmoneim SS, 2009, EUR J ECHOCARDIOGR, V10, P813, DOI 10.1093/ejechocard/jep084
  3. BURKE AP, 1992, CANCER, V69, P387, DOI 10.1002/1097-0142(19920115)69:2<387::AID-CNCR2820690219>3.0.CO;2-N
  4. Gillies Robert J., 1999, Neoplasia (New York), V1, P197, DOI 10.1038/sj.neo.7900037
  5. Haverkamp M C P, 2005, Eur J Echocardiogr, V6, P388, DOI 10.1016/j.euje.2005.02.002
  6. Iordanescu I, 2002, RADIOLOGY, V222, P460, DOI 10.1148/radiol.2222010660
  7. Jang JJ, 2006, J AM SOC ECHOCARDIOG, V19
  8. Kirkpatrick JN, 2004, J AM COLL CARDIOL, V43, P1412, DOI 10.1016/j.jacc.2003.09.065
  9. Kowatsch I, 2007, J AM SOC ECHOCARDIOG, V20, P1109, DOI 10.1016/j.echo.2007.02.008
  10. Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005
  11. Lepper W, 2002, J AM SOC ECHOCARDIOG, V15, P1419, DOI 10.1067/mje.2002.124641
  12. Lima MF, 2013, J AM SOC ECHOCARDIOG, V26, P278, DOI 10.1016/j.echo.2012.12.009
  13. Mattoso AAA, 2013, J AM SOC ECHOCARDIOG, V26, P539, DOI 10.1016/j.echo.2013.01.016
  14. Morais NV, 2012, INT J CARDIOL, V156, P245, DOI 10.1016/j.ijcard.2012.01.046
  15. Moustafa Sherif E, 2008, Eur J Echocardiogr, V9, P326, DOI 10.1093/ejechocard/jen067
  16. Osorio AF, 2007, J AM SOC ECHOCARDIOG, V20, P709, DOI 10.1016/j.echo.2006.11.016
  17. Peltier M, 2004, J AM COLL CARDIOL, V43, P257, DOI 10.1016/j.jacc.2003.07.040
  18. Peters PJ, 2006, J AM SOC ECHOCARDIOG, V19, P230, DOI 10.1016/j.echo.2005.10.015
  19. PORTER TR, 1995, CIRCULATION, V92, P2391
  20. Rainbird AJ, 2001, J AM SOC ECHOCARDIOG, V14, P378, DOI 10.1067/mje.2001.111264
  21. Reynen K, 2004, ANN ONCOL, V15, P375, DOI 10.1093/annonc/mdh086
  22. Reynen K, 1996, AM J CARDIOL, V77, P107, DOI 10.1016/S0002-9149(97)89149-7
  23. Santos JMT, 2010, AM J CARDIOL, V105, P243, DOI 10.1016/j.amjcard.2009.09.009
  24. Trost Biana, 2007, J Nucl Cardiol, V14, pe6, DOI 10.1016/j.nuclcard.2006.11.006
  25. Tsutsui JM, 2005, CIRCULATION, V112, P1444, DOI 10.1161/CIRCULATIONHA.105.537134
  26. Uenishi Eliza Kaori, 2008, Arq Bras Cardiol, V91, pe48, DOI 10.1590/S0066-782X2008001700015
  27. Vogel R, 2005, J AM COLL CARDIOL, V45, P754, DOI 10.1016/j.jacc.2004.11.044
  28. Wei K, 1998, CIRCULATION, V97, P473